Share price at the NSE close on 23 Oct 2026. Previous close ₹301.90.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹26,874 Cr307th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 11 Aug 2026
- 18.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 Jul 2026
- 1.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.87%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 11 Aug 2026
- 10.2%
- NIMNet interest margin. Net interest income ÷ the average assets that earn interest × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026.
- 10.13%
- Cost of fundsCost of funds. Interest paid ÷ the average of what the company pays interest on × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026.
- 8.17%
- Credit costCredit cost. What was set aside for loans that may not be repaid ÷ average loans given × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026.
- 2.96%
- ROAReturn on assets. Profit after tax ÷ average total assets × 100 × 12 ÷ the months in the period, a rate per year; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. It equals net interest income + other income − operating expenses − provisions + exceptional items − tax + the lines below tax, each on the same base. For the year to Mar 2026.
- 1.60%
- LeverageAssets per rupee of net worth. Average total assets ÷ average net worth: rupees of assets for each rupee of net worth; given only where the balance sheets at the start and at the end of the period are both held; not given for an insurer. For the year to Mar 2026.
- 4.34times net worth
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 47,68,61243.3% delivered
Manappuram Finance board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Chairperson and managing directorVazhappully Padmanabhan NandakumarRelated to the promoter
- Company Secretary and Compliance OfficerAPARNA MENON
9 directors5 independent2 executive2 non-executive
- Vazhappully Padmanabhan Nandakumar · Chairperson and managing directorExecutive · joined Jul 1992 · reappointed Aug 2023 · 407 months as independent · 1 listed board · 6 committee seats
- Harshan Sankarakutty KollaraIndependent · joined Aug 2020 · reappointed Aug 2025 · 70 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
- Sumitha NandanExecutive · joined Jan 2023 · reappointed Aug 2025 · 41 months as independent · 1 listed board · 2 committee seats
- Ashish Arvind KotechaNon-executive · joined May 2026 · 1 month as independent · 1 listed board
- Balaji Veeravalli VijayaraghavanIndependent · joined May 2026 · 1 month as independent · 1 listed board · 1 as independent · 3 committee seats
- Rajesh Kumar RathanchandIndependent · joined May 2026 · 1 month as independent · 1 listed board · 1 as independent · 3 committee seats
- Rakesh Induprasad BhattIndependent · joined May 2026 · 1 month as independent · 1 listed board · 1 as independent · 1 committee seat
- Rishi MandawatNon-executive · joined May 2026 · 1 month as independent · 3 listed boards · 2 committee seats, 1 as chair
- Rosemary SebastianIndependent · joined May 2026 · 1 month as independent · 3 listed boards · 3 as independent · 6 committee seats, 4 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
7 directors who left
- Abhijit Sen, left 5 May 2026: Others
- Pratima Ram, left 5 May 2026: Others
- V P Seemandini, left 5 May 2026: Others
- T C Suseel Kumar, left 5 May 2026: Others
- Sankaran Nair Rajagopal, left 5 May 2026: Others
- Edodiyil Kunhiraman Bharat Bhushan, left 5 May 2026: Others
- Shailesh Jayantilal Mehta, left 27 Aug 2025: Tenure Completion
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 23 Jun 20269 of 9 present5 independent · 41 days in between
- 12 May 20269 of 9 present5 independent · 6 days in between
- 5 May 20269 of 9 present7 independent · no day in between
- 4 May 20269 of 9 present7 independent · 34 days in between
2 earlier meetings
- 30 Mar 20269 of 9 present7 independent · 59 days in between
- 29 Jan 20269 of 9 present7 independent
Audit Committee
Chair Rosemary Sebastian
Harshan Kollara Sankarakutty, Sumitha Nandan, Rajesh Kumar, Rakesh Bhatt
- 12 May 20265 of 5 present4 independent · 9 days in between
- 2 May 20265 of 5 present4 independent · 32 days in between
- 30 Mar 20265 of 5 present4 independent · 60 days in between
- 28 Jan 20265 of 5 present4 independent · no day in between
1 earlier meeting
- 27 Jan 20265 of 5 present4 independent
Nomination and remuneration committee
Chair Rakesh Bhatt
Ashish Arvind Kotecha, Rajesh Kumar, Rosemary Sebastian, Balaji Vijayaraghavan
- 23 Jun 20265 of 5 present4 independent · 41 days in between
- 12 May 20265 of 5 present4 independent · 7 days in between
- 4 May 20263 of 3 present3 independent · 34 days in between
- 30 Mar 20263 of 3 present3 independent · 38 days in between
2 earlier meetings
- 19 Feb 20262 of 3 present2 independent · 20 days in between
- 29 Jan 20263 of 3 present3 independent
Stakeholders Relationship Committee
Chair Harshan Kollara Sankarakutty
Rosemary Sebastian, Sumitha Nandan
- 27 Apr 20265 of 5 present4 independent · 99 days in between
- 17 Jan 20265 of 5 present4 independent
Risk Management Committee
Chair Rajesh Kumar
Ashish Arvind Kotecha, Sumitha Nandan
- 23 Jun 20263 of 3 present1 independent · 51 days in between
- 2 May 20264 of 5 present4 independent · 93 days in between
- 28 Jan 20265 of 5 present4 independent
Corporate Social Responsibility Committee
Chair V.P. Nandakumar
Harshan Kollara Sankarakutty, Rakesh Bhatt
- 27 Apr 20265 of 5 present4 independent · 27 days in between
- 30 Mar 20265 of 5 present4 independent · 71 days in between
- 17 Jan 20265 of 5 present4 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditors
Named in the results for the quarter to Jun 2026.
- KKC & Associates LLP, Chartered AccountantsPeer-review certificate valid to Jul 2027
- Chokshi & Chokshi LLP, Chartered AccountantsPeer-review certificate valid to Mar 2028
2 earlier auditors
- KKC & Associates LLP, Chaftered AccountantsNamed in the filing for the quarter to Mar 2025
- Chokshi & Chokhi LLP, Chartered AccountantsNamed in the filing for the quarter to Mar 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Manappuram Finance AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Manappuram Finance dividend history
Annual general meeting, 12 Aug 2026
5,31,570 shareholders on the register on 5 Aug 2026; present: 4 promoters and 585 others; votes counted by Suresh M. V / SMS and CO Company Secretaries LLP.The company's voting result (opens in a new tab)
To consider and adopt the audited Standalone as well as Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2026, together with Reports of the Board of Directors and Auditors thereon.MoreLess
Ordinary100.00% for0.00% againstAgainst: promoters 0.00% · institutions 0.00% · other public 1.02%
Turnout: all 73.59% · promoters 99.99% · institutions 83.24% · other public 0.42%
- Appointment of Dr. Sumitha Nandan (DIN: 03625120) as a Director, liable to retire by rotation and being eligible, seeks re-appointmentOrdinaryPromoters have an interest in it87.57% for12.43% against
Against: promoters 0.00% · institutions 28.68% · other public 5.83%
Turnout: all 73.61% · promoters 99.99% · institutions 83.29% · other public 0.42%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Extraordinary general meeting, 14 Jul 2026, 6 resolutions
5,32,605 shareholders on the register on 7 Jul 2026; present: 1 promoter and 74 others; votes counted by Suresh M. V / SMS and CO Company Secretaries LLP.The company's voting result (opens in a new tab)
- 1 - Appointment of Mr. Rishi Mandawat (DIN: 07639602) as a Non-Executive Non Independent Director of the Company.OrdinaryPromoters have an interest in it99.96% for0.04% against
Against: promoters 0.00% · institutions 0.10% · other public 2.56%
Turnout: all 72.74% · promoters 99.99% · institutions 82.53% · other public 0.41%
- 2 - Appointment of Mr. Ashish Arvind Kotecha (DIN: 02384614) as a Non-Executive Non Independent Director of the Company.OrdinaryPromoters have an interest in it99.78% for0.22% against
Against: promoters 0.00% · institutions 0.52% · other public 2.56%
Turnout: all 72.74% · promoters 99.99% · institutions 82.53% · other public 0.41%
- 3 - Appointment of Mr. Rajesh Kumar Rathanchand (DIN: 08708450) as a Non-Executive Independent Director of the Company.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.56%
Turnout: all 72.74% · promoters 99.99% · institutions 82.53% · other public 0.41%
- 4 - Appointment of Mr. Balaji Vijayaraghavan (DIN: 05122430) as a Non-Executive Independent Director of the Company.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.51%
Turnout: all 72.74% · promoters 99.99% · institutions 82.53% · other public 0.41%
- 5 - Appointment of Mr. Rakesh Bhatt (DIN: 02531541) as a Non-Executive Independent Director of the Company.Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.51%
Turnout: all 72.74% · promoters 99.99% · institutions 82.53% · other public 0.41%
- 6 - Appointment of Ms. Rosemary Sebastian (DIN: 07938489) as a Non-Executive Independent Director of the Company.Special99.95% for0.05% against
Against: promoters 0.00% · institutions 0.11% · other public 2.51%
Turnout: all 72.74% · promoters 99.99% · institutions 82.53% · other public 0.41%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Extraordinary general meeting, 22 Jan 2026, 3 resolutions
5,71,486 shareholders on the register on 15 Jan 2026; present: 1 promoter and 59 others; votes counted by Suresh M. V / SMS and CO Company Secretaries LLP.The company's voting result (opens in a new tab)
- 1 - Approval to borrow in excess of the aggregate of paid-up share capital and free reserves and securities premium of the Company under Section 180(1)(c) of the Companies Act, 2013.Special98.95% for1.05% against
Against: promoters 0.00% · institutions 2.12% · other public 0.39%
Turnout: all 70.67% · promoters 99.99% · institutions 88.22% · other public 2.00%
- 2 - Approval to create charge/mortgage over the proper es of the Company for the purpose of borrowing in terms of Sec on 180(1)(a) of the Companies Act, 2013.Special98.95% for1.05% against
Against: promoters 0.00% · institutions 2.12% · other public 0.39%
Turnout: all 70.67% · promoters 99.99% · institutions 88.22% · other public 2.00%
- 3 - Revision in terms of remuneration payable to Dr Sumitha Nandan (DIN: 03625120), Whole-me Director of the Company.OrdinaryPromoters have an interest in it92.81% for7.19% against
Against: promoters 0.00% · institutions 14.59% · other public 0.92%
Turnout: all 70.44% · promoters 99.99% · institutions 87.63% · other public 2.00%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 14 Aug 2025, 7 resolutions
5,99,033 shareholders on the register on 7 Aug 2025; present: 3 promoters and 741 others; votes counted by Suresh MV / SMS & CO COMPANY SECRETARIES LLP.The company's voting result (opens in a new tab)
To consider and adopt the audited Standalone as well as Consolidated Financial Statements of the Company for the financial year ended March 31, 2025, together with Reports of the Board of Directors and Auditors thereon.MoreLess
Ordinary98.94% for1.06% againstAgainst: promoters 0.00% · institutions 2.25% · other public 0.14%
Turnout: all 68.15% · promoters 99.99% · institutions 82.64% · other public 3.02%
- Appointment of Dr. Sumitha Nandan (DIN: 03625120) as a director, liable to retire by rotation.Ordinary78.09% for21.91% against
Against: promoters 0.00% · institutions 47.09% · other public 0.51%
Turnout: all 67.39% · promoters 99.99% · institutions 80.68% · other public 3.02%
- Appointment of KSR and Co Company Secretaries LLP, as Secretarial Auditor of the Company.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.30%
Turnout: all 68.21% · promoters 99.99% · institutions 82.79% · other public 3.02%
- Re-appointment of Mr. Harshan Kollara Sankarakutty (DIN: 01519810) as an Independent Director of the Company.Special98.87% for1.13% against
Against: promoters 0.00% · institutions 2.38% · other public 0.39%
Turnout: all 68.23% · promoters 99.99% · institutions 82.84% · other public 3.02%
- Revision in remuneration payable to Dr. Sumitha Nandan (DIN: 03625120), Whole-time Director of the Company.Ordinary94.34% for5.66% against
Against: promoters 0.00% · institutions 11.98% · other public 0.56%
Turnout: all 68.23% · promoters 99.99% · institutions 82.84% · other public 3.02%
- To consider and approve ‘Manappuram Finance Limited - Employee Stock Option Scheme 2025’.Special82.16% for17.84% against
Against: promoters 0.00% · institutions 37.88% · other public 0.52%
Turnout: all 68.08% · promoters 99.99% · institutions 82.45% · other public 3.02%
- To consider and approve grant of employee stock options to the employees of subsidiary company (ies) of the Company under ‘Manappuram Finance Limited - Employee Stock Option Scheme 2025’.Special82.20% for17.80% against
Against: promoters 0.00% · institutions 37.80% · other public 0.52%
Turnout: all 68.08% · promoters 99.99% · institutions 82.45% · other public 3.02%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Extraordinary general meeting, 16 Apr 2025, 4 resolutions
6,47,053 shareholders on the register on 9 Apr 2025; present: 1 promoter and 88 others; votes counted by Suresh M. V / SMS and CO Company Secretaries LLP.The company's voting result (opens in a new tab)
- Increase in the Authorised Share Capital of the Company and Alteration in the Capital Clause of the Memorandum of the Company.Ordinary98.80% for1.20% against
Against: promoters 0.00% · institutions 2.60% · other public 0.02%
Turnout: all 67.15% · promoters 100.00% · institutions 83.06% · other public 3.31%
- Amendment to the Articles of Association of the Company.Special98.80% for1.20% against
Against: promoters 0.00% · institutions 2.60% · other public 0.02%
Turnout: all 67.15% · promoters 100.00% · institutions 83.06% · other public 3.31%
- Issuance of Equity Shares and Warrants by way of Preferential Issue on a Private Placement Basis.Special99.53% for0.47% against
Against: promoters 0.00% · institutions 1.02% · other public 0.05%
Turnout: all 66.99% · promoters 100.00% · institutions 82.62% · other public 3.31%
- To Consider and approve the (I) Adoption of the Amended and Restated Articles of Association of the Company; and (II) Grant of Special Rights to Identified Shareholders of the Company.Special91.63% for8.37% against
Against: promoters 0.00% · institutions 18.13% · other public 0.03%
Turnout: all 67.15% · promoters 100.00% · institutions 83.06% · other public 3.31%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 14 Aug 2024, 7 resolutions
Present: 4 promoters and 608 others.The company's voting result (opens in a new tab)
1 - To receive, consider and adopt the audited Standalone as well as Consolidated Financial Statements of the Company for the financial year ended March 31, 2024, together with Reports of the Board of Directors and Auditors thereon.MoreLess
Ordinary99.88% for0.12% againstAgainst: promoters 0.00% · institutions 0.23% · other public 0.33%
Turnout: all 73.32% · promoters 100.00% · institutions 86.29% · other public 3.17%
- 2 - To appoint a director in place of Dr. Sumitha Nandan (DIN: 03625120), Executive Director of the Company who retires by rotation, and being eligible, offers herself for re-appointment.Ordinary71.10% for28.90% against
Against: promoters 0.00% · institutions 56.41% · other public 1.99%
Turnout: all 73.52% · promoters 100.00% · institutions 86.73% · other public 3.17%
- 3 - Appointment of M/s. KKC & Associates LLP (ICAI Firm Registration No. 105146W/ W100621) as Joint Statutory Auditor of the Company and to fix their remuneration.Ordinary99.88% for0.12% against
Against: promoters 0.00% · institutions 0.22% · other public 0.47%
Turnout: all 73.52% · promoters 100.00% · institutions 86.73% · other public 3.17%
- 4 - Appointment of M/s. Chokshi & Chokshi LLP (ICAI Firm Registration No. 101872W/W100045) as Joint Statutory Auditor of the Company and to fix their remunerationOrdinary99.87% for0.13% against
Against: promoters 0.00% · institutions 0.22% · other public 1.69%
Turnout: all 73.52% · promoters 100.00% · institutions 86.73% · other public 3.17%
- 5 - Re-appointment of Mr. Abhijit Sen (DIN: 00002593) as Independent Director.Special99.13% for0.87% against
Against: promoters 0.00% · institutions 1.69% · other public 0.57%
Turnout: all 73.52% · promoters 100.00% · institutions 86.73% · other public 3.17%
- 6 - Revision in remuneration payable to Mr. V P Nandakumar (DIN: 00044512), Managing Director & Chief Executive Officer of the Company.Ordinary71.58% for28.42% against
Against: promoters 0.00% · institutions 55.49% · other public 1.09%
Turnout: all 73.52% · promoters 100.00% · institutions 86.73% · other public 3.17%
- 7 - Revision in remuneration payable to Dr. Sumitha Nandan (DIN: 03625120), Whole-time Director of the Company.Ordinary90.79% for9.21% against
Against: promoters 0.00% · institutions 17.94% · other public 2.37%
Turnout: all 73.52% · promoters 100.00% · institutions 86.73% · other public 3.17%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 11 May 2024, 2 resolutions
The company's voting result (opens in a new tab)
- Approval to borrow in excess of the aggregate of paid-up share capital and free reserves and securities premium of the Company under Section 180(1)(c) of the Companies Act, 2013.Special98.70% for1.30% against
Against: promoters 0.00% · institutions 2.61% · other public 1.89%
Turnout: all 70.38% · promoters 99.99% · institutions 81.44% · other public 3.47%
- Approval to create charge/ mortgage over the properties of the Company for the purpose of borrowing in terms of Section 180(1)(a) of the Companies Act, 2013.Special98.70% for1.30% against
Against: promoters 0.00% · institutions 2.61% · other public 1.80%
Turnout: all 70.38% · promoters 99.99% · institutions 81.44% · other public 3.47%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 3 Apr 2024, 1 resolution
The company's voting result (opens in a new tab)
- Appointment of Mr. Edodiyil Kunhiraman Bharat Bhushan (DIN: 01124966) as Non-Executive Independent Director of the CompanSpecial99.98% for0.02% against
Against: promoters 0.00% · institutions 0.00% · other public 1.66%
Turnout: all 69.15% · promoters 99.99% · institutions 78.58% · other public 3.57%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it
Mutual fund votes, meeting of 12 Aug 2026, 13 fund houses so far (houses' deadline to file 15 Oct 2026)
To consider and adopt the audited Standalone as well as Consolidated Financial Statements of the Company for the Financial Year ended March 31, 2026, together with Reports of the Board of Directors and Auditors thereon.MoreLess
13 for0 against- Appointment of Dr. Sumitha Nandan (DIN: 03625120) as a Director, liable to retire by rotation and being eligible, seeks re-appointment13 for0 against
Mutual fund votes, meeting of 14 Jul 2026, 13 fund houses so far (houses' deadline to file 15 Oct 2026)
- 1 - Appointment of Mr. Rishi Mandawat (DIN: 07639602) as a Non-Executive Non Independent Director of the Company.13 for0 against
- 2 - Appointment of Mr. Ashish Arvind Kotecha (DIN: 02384614) as a Non-Executive Non Independent Director of the Company.13 for0 against
- 3 - Appointment of Mr. Rajesh Kumar Rathanchand (DIN: 08708450) as a Non-Executive Independent Director of the Company.13 for0 against
- 4 - Appointment of Mr. Balaji Vijayaraghavan (DIN: 05122430) as a Non-Executive Independent Director of the Company.13 for0 against
- 5 - Appointment of Mr. Rakesh Bhatt (DIN: 02531541) as a Non-Executive Independent Director of the Company.13 for0 against
- 6 - Appointment of Ms. Rosemary Sebastian (DIN: 07938489) as a Non-Executive Independent Director of the Company.13 for0 against
6 earlier meetings
Mutual fund votes, meeting of 22 Jan 2026, 30 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
- 1 - Approval to borrow in excess of the aggregate of paid-up share capital and free reserves and securities premium of the Company under Section 180(1)(c) of the Companies Act, 2013.26 for0 against
- 3 - Revision in terms of remuneration payable to Dr Sumitha Nandan (DIN: 03625120), Whole-me Director of the Company.
Against ICICI Prudential Mutual Fund, Invesco Mutual Fund, Jio BlackRock Mutual Fund, Kotak Mahindra Mutual Fund, Mirae Asset Mutual Fund, Nippon India Mutual Fund, UTI Mutual Fund, WhiteOak Capital Mutual Fund
- ICICI Prudential Mutual FundThe revision in remuneration is with respect to restructuring of the salary with respect to contribution to EPF. Dr. Sumitha Nandan, is the daughter of promoter, and was appointed on the board on 1 January 2023. Her remuneration is high in comparison to remuneration paid to the Senior Management Personnel in the company with more relevant experience. She is also entitled to a commission component, which is open ended at 1% of profits. The company must cap the overall commission/variable pay. Further, she is entitled to travel expenses for self and family thrice in a year. The AMC believe such expenses are personal in nature and must be borne by the employee. Hence, the AMC has voted against the resolution
- Invesco Mutual FundAs per the revised terms, we estimate Dr. Sumitha Nandan’s FY26 remuneration at Rs. 43.5 mn which could go as high as Rs. 167.4 mn if commission is paid at similar range as to CMD V.P. Nandakumar. Although, the estimated minimum remuneration is not high in comparison size and scale of business, she is eligible to receive commission, open ended at 1% of profits. Given a lack of a track record, commission though nominal at 0.05% in FY25, could be much higher than estimated. The company must consider setting a cap to commission to ensure remuneration is reasonable and in alignment with industry peers. We also note, remuneration is not commensurate with remuneration paid to Senior Management Personnel in the company with more relevant experience. We raise further concern that she is entitled to travel expenses for self and family thrice in a year and all medical expenses for self and family. We believe such expenses are personal in nature and must be borne by the employee herself, and not by the company. Lastly her remuneration was revised in the AGM of 2025 and the reason for another revision in less than 6 months remains unclear. We do not support this resolution
- Jio BlackRock Mutual FundAs per the revised terms, we estimate Dr. Sumitha Nandan’s FY26 remuneration at Rs 43.5 mn which could go as high as Rs. 167.4 mn if commission is paid at similar range as to CMD V.P. Nandakumar. Although, the estimated minimum remuneration is not high in comparison size and scale of business, she is eligible to receive commission, open ended at 1% of profits. Given a lack of a track record, commission though nominal at 0.05% in FY25, could be much higher than estimated. The company must consider setting a cap to commission to ensure remuneration is reasonable and in alignment with industry peers. We also note, remuneration is not commensurate with remuneration paid to Senior Management Personnel in the company with more relevant experience. We raise further concern that she is entitled to travel expenses for self and family thrice in a year and all medical expenses for self and family. We believe such expenses are personal in nature and must be borne by the employee herself, and not by the company. Lastly her remuneration was revised in the AGM of 2025 and the reason for another revision in less than 6 months remains unclear. We do not support this resolution.
- Kotak Mahindra Mutual FundMs. Sumitha Nandan, 45, Executive Director at Manappuram Finance Ltd. Dr. Sumitha Nandan has held various executive positions at Manappuram Finance Limited, including Chief Executive Officer of Online Gold Loan (OGL), where she demonstrated strong business acumen and managerial skills. With her experience in healthcare, which emphasizes intense consumer focus and regulatory oversight, combined with her experience in financial services, Dr. Nandan is well-attuned to consumer expectations - a critical area of regulatory focus and concern. As per the revised terms, we estimate Dr. Sumitha Nandan s FY26 remuneration at Rs 43.5 mn which could go as high as Rs. 167.4 mn. Considering the Company s past remuneration practices for Ms. Sumitha Nandan, the proposed remuneration appears fair and reasonable. We raise concern that she is entitled to travel expenses for self and family thrice in a year and all medical expenses for self and family. We believe such expenses are personal in nature and must be borne by the employee herself, and not by the company. Hence, we do not support the resolution.
- Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
- Nippon India Mutual FundGovernance & Transparency Concern: Inadequate clarity on remuneration. No absolute cap on variable pay.
- UTI Mutual FundAs per the revised terms, we estimate Dr. Sumitha Nandan’s FY26 remuneration at Rs 43.5 mn which could go as high as Rs. 167.4 mn if commission is paid at similar range as to CMD V.P. Nandakumar. Given a lack of a track record, commission though nominal at 0.05% in FY25, could be much higher than estimated. The company must consider setting a cap to commission to ensure remuneration is reasonable and in alignment with industry peers. We also note, remuneration is not commensurate with remuneration paid to Senior Management Personnel in the company with more relevant experience. Lastly her remuneration was revised in the AGM of 2025 and the reason for another revision in less than 6 months remains unclear. We do not support this resolution.
- WhiteOak Capital Mutual FundDr. Sumitha Nandan, 45, is daughter of the promoter and Managing Director, V P Nandakumar and she was appointed as Whole-Time Director in 2023. As per the revised terms, Dr. Sumitha Nandan’s FY26 remuneration could rise significantly due to an open-ended commission of up to 1% of profits. Historically she has been paid commission of 0.05% in 2025. On account of this, we recommend voting against.
22 for8 against
6 proposals not matched to one resolution
- 1) Approve increase in borrowing limits to Rs. 750.0 bn to Rs. 400.0 bn.1 for0 against
- 2) Approve creation of charge over assets to secure borrowings up to Rs. 750.0 bn.1 for0 against
- Approve creation of charge over assets to secure borrowings up to Rs. 750.0 bn3 for0 against
- Approve increase in borrowing limits to Rs. 750.0 bn to Rs. 400.0 bn3 for0 against
- Approve Pledging of Assets for Debt2 for0 against
To mortgage and/or charge in addition to the mortgages/ charges created/ to be created by the company in such form and manner and on such ranking and at such time and on such terms as the Board may determine, on all or any of the movable and/or immovable properties of the company both present and future and/ or the whole or any part of the undertaking of the company in favour of the lender, agent, trustees for securing the borrowings of the company availed/to be availed by way of loan in foreign currency and/or in rupee currency and securities comprising of fully/partly convertible debentures and/or secured premium notes and/or floating rates notes, bonds or other debt instruments issued/to be issued by the company from time to time in one or more tranches up to an aggregate limit of Rs. 75,000 Crores.MoreLess
24 for0 against
Mutual fund votes, meeting of 14 Aug 2025, 26 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
To consider and adopt the audited Standalone as well as Consolidated Financial Statements of the Company for the financial year ended March 31, 2025, together with Reports of the Board of Directors and Auditors thereon.MoreLess
Against Angel One Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund
- Angel One Mutual FundFinancial statements of subsidiaries not disclosed on website
- Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual FundUnqualified Financial Statements. Non-Compliant with Companies Act, 2013 & SEBI LODR Regulations: Non-disclosure of financial statements of Subsidiaries for FY 2022-23 on website.
- Nippon India Mutual FundNon-Compliant with Companies Act, 2013 & SEBI LODR Regulations: Non-disclosure of financial statements of Subsidiaries for FY 2022-23 on website.
20 for6 against- Appointment of Dr. Sumitha Nandan (DIN: 03625120) as a director, liable to retire by rotation.
Against Franklin Templeton Mutual Fund
- Franklin Templeton Mutual FundA vote AGAINST the following nominee is warranted because Sumitha Jayasankar is an executive director serving on the audit committee.
24 for1 against - Appointment of KSR and Co Company Secretaries LLP, as Secretarial Auditor of the Company.26 for0 against
- Re-appointment of Mr. Harshan Kollara Sankarakutty (DIN: 01519810) as an Independent Director of the Company.
Against Angel One Mutual Fund, Bajaj Finserv Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund
- Angel One Mutual FundGovernance Concern: Proposed term will lead to prolonged association with the Group.
- Bajaj Finserv Mutual FundCompliant with law. Governance Concern: Proposed term will lead to Prolonged Association with the Group. "The company is seeking shareholders' approval for the reappointment of Mr. Harshan Kollara Sankarakutty as an Independent Director of the Company. This resolution is significant as it pertains to the governance and oversight of the company by ensuring that the board comprises individuals with the necessary expertise and independence. However, there is a governance concern regarding the proposed term of Mr. Harshan Kollara Sankarakutty. If the proposed reappointment is approved, Mr. Sankarakutty would complete a total association of 10 years on January 28, 2030. This prolonged association with the company raises concerns about his independence. According to best governance practices, an independent director should not have an association exceeding 10 years with the company, as it may compromise their ability to provide unbiased and independent judgment. In addition to this, we reached out to the company regarding this matter but did not receive any response. This lack of communication from the company further exacerbates our concerns about the transparency and responsiveness of the board. In view of the above, we are raising a governance concern with respect to the reappointment under resolution 4. Therefore, we are voting against this resolution."
- Edelweiss Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Navi Mutual FundCompliant with law. Governance Concern: Proposed term will lead to Prolonged Association with the Group.
- Nippon India Mutual FundGovernance Concern: Proposed term will lead to Prolonged Association with the Group.
19 for7 against - Revision in remuneration payable to Dr. Sumitha Nandan (DIN: 03625120), Whole-time Director of the Company.
Against Aditya Birla Sun Life Mutual Fund, Axis Mutual Fund, ICICI Prudential Mutual Fund, UTI Mutual Fund
- Aditya Birla Sun Life Mutual Fund, Axis Mutual FundDr. Sumitha Nandan, 45, daughter of promoter, Managing Director, V.P. Nandakumar was appointed on the board on 1 January 2023. For FY25, she was paid a remuneration of Rs. 25.5 mn. Her remuneration post revision is estimated at Rs 37.1, which is high in comparison to remuneration paid to the Senior Management Personnel in the company with more relevant experience. Her remuneration structure has a minimum annual increase of 10% in fixed pay: the company must disclose if such minimum increases in fixed pay are committed to all other employees as well. Dr. Sumitha Nandan is also entitled to a commission component, which is open ended at 1% of profits. The company must cap the overall commission/variable pay and disclose the performance parameters considered to determine the variable pay. Further, we raise a concern that she is entitled to travel expenses for self and family thrice in a year and also reimbursement of medical expenses for self and family. We believe such expenses are personal in nature and must be borne by the employee herself, and not by the company. Hence, we do not support the resolution.
- ICICI Prudential Mutual FundDr. Sumitha Nandan, is the daughter of promoter, and was appointed on the board on 1 January 2023. Her remuneration is high in comparison to remuneration paid to the Senior Management Personnel in the company with more relevant experience. She is also entitled to a commission component, which is open ended at 1% of profits. The company must cap the overall commission/variable pay. Further, she is entitled to travel expenses for self and family thrice in a year. The AMC believe such expenses are personal in nature and must be borne by the employee. Hence, the AMC has voted against the resolution.
- UTI Mutual FundDr. Sumitha Nandan, 45, daughter of promoter, Managing Director, V.P. Nandakumar was appointed on the board on 1 January 2023. For FY25, she was paid a remuneration of Rs. 25.5 mn. Her remuneration post revision is estimated at Rs 37.1, which is high in comparison to remuneration paid to the Senior Management Personnel in the company with more relevant experience. We do not support the resolution.
22 for4 against - To consider and approve ‘Manappuram Finance Limited - Employee Stock Option Scheme 2025’.
Against Franklin Templeton Mutual Fund, HDFC Mutual Fund, HSBC Mutual Fund
- Franklin Templeton Mutual FundA vote AGAINST this resolution is warranted because: • The stock options may be issued with an exercise price at a discount to the market price on the date of grant. • The company has not disclosed the weightage, performance targets and thresholds for vesting, thus making it difficult to ascertain if the performance targets will be sufficiently stretching.
- HDFC Mutual FundLack of clarity on the pricing of the ESOPS. We do not support the resolution.
- HSBC Mutual FundA vote AGAINST these resolutions is warranted because:• The stock options may be issued with an exercise price at a discount to the market price on the date ofgrant.• The company has not disclosed the weightage, performance targets and thresholds for vesting, thusmaking it difficult to ascertain if the performance targets will be sufficiently stretching.
22 for3 against - To consider and approve grant of employee stock options to the employees of subsidiary company (ies) of the Company under ‘Manappuram Finance Limited - Employee Stock Option Scheme 2025’.
Against Franklin Templeton Mutual Fund, HDFC Mutual Fund, HSBC Mutual Fund
- Franklin Templeton Mutual FundA vote AGAINST this resolution is warranted because: • The stock options may be issued with an exercise price at a discount to the market price on the date of grant. • The company has not disclosed the weightage, performance targets and thresholds for vesting, thus making it difficult to ascertain if the performance targets will be sufficiently stretching.
- HDFC Mutual FundLack of clarity on the pricing of the ESOPS. We do not support the resolution.
- HSBC Mutual FundA vote AGAINST these resolutions is warranted because:• The stock options may be issued with an exercise price at a discount to the market price on the date ofgrant.• The company has not disclosed the weightage, performance targets and thresholds for vesting, thusmaking it difficult to ascertain if the performance targets will be sufficiently stretching.
23 for3 against
2 proposals not matched to one resolution
- Approve extension of Manappuram Finance Limited - Employee Stock Option Scheme 2025 (ESOP 2025) to the employees of subsidiary company (ies)1 for0 against
- Dr. Sumitha Nandan (DIN: 03625120) who retires by rotation at this meeting, and being eligible for re-appointment.1 for0 against
Mutual fund votes, meeting of 16 Apr 2025, 30 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
- Increase in the Authorised Share Capital of the Company and Alteration in the Capital Clause of the Memorandum of the Company.30 for0 against
- Amendment to the Articles of Association of the Company.29 for0 against
- Issuance of Equity Shares and Warrants by way of Preferential Issue on a Private Placement Basis.
Against Angel One Mutual Fund, Groww Mutual Fund, HSBC Mutual Fund, Navi Mutual Fund
- Angel One Mutual FundGovernance Concern: Warrants priced exactly at par with Equity Shares through ICDR Pricing Mechanism.
- Groww Mutual Fund, Navi Mutual FundCompliant with law. Governance Concern: Warrants priced exactly at par with Equity Shares through ICDR Pricing Mechanism.
- HSBC Mutual FundBy its inherent nature, warrants are at-risk instruments which provide no guarantee of full conversionand final capital infusion.
25 for4 against - To Consider and approve the (I) Adoption of the Amended and Restated Articles of Association of the Company; and (II) Grant of Special Rights to Identified Shareholders of the Company.
Against Angel One Mutual Fund, Axis Mutual Fund, Bandhan Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, ICICI Prudential Mutual Fund, Invesco Mutual Fund, Kotak Mahindra Mutual Fund, Mirae Asset Mutual Fund, Navi Mutual Fund, Nippon India Mutual Fund, NJ Mutual Fund, SBI Mutual Fund, Unifi Mutual Fund, UTI Mutual Fund
- Angel One Mutual FundGovernance Concern: Nomination Rights provided to the Acquirer Promoters as well as Existing Promoters, which may limit the role of NRC, Provision to appoint Alternate Directors included in the proposed Articles of Association, Provision to combine the position of Chairperson & Executive Director / Managing Director. Combining the position of Chairman with executive positions blurs the demarcation between Board and Management
- Axis Mutual Fund, NJ Mutual Fund, SBI Mutual Fund, Unifi Mutual FundThe company proposes to amend its Articles of Association (AoA) to incorporate special rights from shareholder agreements between Bain Capital and the existing promoters. The amendments grant Bain and the promoters the right to nominate directors to the board and its committees as long as they hold at least 5% of the share capital. They also have mutual quorum rights in board and general meetings, committee nomination rights, and affirmative voting rights on reserved matters while holding at least 10% equity. Additionally, if V.P. Nandakumar is appointed as a promoter nominee director in any group company, he will serve as its Chairperson. The company has disclosed the draft articles in the notice to the shareholders as well as on their website. Bain Capital (through its affiliates) can appoint a nominee director on the board as long as they hold 5% of the equity share capital: which is low. The proposed articles include committee nomination rights and quorum rights to both sets of promoters – both of which we do not support. Further, as per the articles Bain Capital and the existing promoters have affirmative voting rights - we believe that such rights compromise the independence and functioning of the board. We do not support the resolution.
- Bandhan Mutual Fund, Invesco Mutual FundThe company proposes to amend its Articles of Association (AoA) to incorporate special rights from shareholder agreements between Bain Capital and the existing promoters. The amendments grant Bain and the promoters the right to nominate directors to the board and its committees as long as they hold at least 5% of the share capital. They also have mutual quorum rights in board and general meetings, committee nomination rights, and affirmative voting rights on reserved matters while holding at least 10% equity. Additionally, if V.P. Nandakumar is appointed as a promoter nominee director in any group company, he will serve as its Chairperson. The company has disclosed the draft articles in the notice to the shareholders as well as on their website. Bain Capital (through its affiliates) can appoint a nominee director on the board as long as they hold 5% of the equity share capital: which is low. The proposed articles include committee nomination rights and quorum rights to both sets of promoters – both of which we do not support. Further, as per the articles Bain Capital and the existing promoters have affirmative voting rights - we believe that such rights compromise the independence and functioning of the board. We do not support the resolution
- Groww Mutual Fund, Navi Mutual FundCompliant with law. Governance Concern: Nomination Rights provided to the Acquirer Promoters as well as Existing Promoters, which may limit the role of NRC, Provision to appoint Alternate Directors included in the proposed AoA, Provision to combine the position of Chairperson & ED / MD.
- HDFC Mutual FundBain Capital can appoint a nominee director on the board as long as they hold 5% of the equity share capital: which is low. We do not support the resolution.
- ICICI Prudential Mutual FundThe company proposes to amend its Articles of Association (AoA) to incorporate special rights from shareholder agreements between Bain Capital and the existing promoters. The amendments grant Bain and the promoters the right to nominate directors to the board and its committees as long as they hold at least 5% of the share capital. Bain Capital (through its affiliates) can appoint a nominee director on the board as long as they hold 5% of the equity share capital: which is low. The AMC has voted against the resolution as the shareholding threshold for these rights is low.
- Kotak Mahindra Mutual FundThe company has proposed to amend its Articles of Association (AoA) to incorporate special rights from shareholder agreements between Bain Capital and the existing promoters. The amendments grant Bain and the promoters the right to nominate directors to the board and its committees as long as they hold at least 5% of the share capital. They also have mutual quorum rights in board and general meetings, committee nomination rights, and affirmative voting rights on reserved matters while holding at least 10% equity. Additionally, if V.P. Nandakumar is appointed as a promoter nominee director in any group company, he will serve as its Chairperson. Bain Capital (through its affiliates) can appoint a nominee director on the board as long as they hold 5% of the equity share capital: which we believe is low. The proposed articles also include committee nomination rights and quorum rights to both sets of promoters. Further, as per the articles Bain Capital and the existing promoters have affirmative voting rights - we believe that such rights compromise the independence and functioning of the board. Hence we do not support the resolution.
- Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
- Nippon India Mutual FundGovernance Concern: Nomination Rights provided to the Acquirer Promoters as well as Existing Promoters, which may limit the role of NRC,
- UTI Mutual FundBain Capital (through its affiliates) can appoint a nominee director on the board as long as they hold 5% of the equity share capital: which is low. The proposed articles include committee nomination rights and quorum rights to both sets of promoters – both of which we do not support. Further, as per the articles Bain Capital and the existing promoters have affirmative voting rights - we believe that such rights compromise the independence and functioning of the board. We do not support the resolution.
12 for15 against
4 proposals not matched to one resolution
- Amend Articles of Association2 for0 against
To amend and restate the existing articles of association of the Company (“AoA”) by incorporating the relevant terms of the 5|23 Shareholders' Agreement dated March 20, 2025 executed by and amongst the Company, BC Asia Investments XXV Limited (“Investor 1”), BC Asia Investments XIV Limited (“Investor 2”) (collectively, the “Investors”) and V.P. Nandakumar, Sushama Nandakumar (collectively, the “Exisng Promoters”), Suhas Nandan, Sooraj Nandan, and Sumitha Nandan (the “SHA”), and adopt the amended and restated AoA with effect from closing under the Securities Subscription Agreement dated March 20, 2025 as executed between the Company, the Investors and V.P. Nandakumar, Sushama Nandakumar, Sumitha Nandan, Suhas Nandan and Sooraj Nandan (the “SSA”) and in accordance with the SHA, in substitution for, and to the exclusion of, the existing AoAMoreLess
Against Helios Mutual Fund
- Helios Mutual FundCompliant with law. Governance Concern: Nomination Rights provided to the Acquirer Promoters as well as Existing Promoters, which may limit the role of NRC, Provision to appoint Alternate Directors included in the proposed AoA, Provision to combine the position of Chairperson & ED / MD.
0 for1 against- To approve an amendment of the Articles of Association of the Company by inserting the new clause as Article 6A1 for0 against
To Authorize Board of Directors to create, offer, issue and allot (I) 9,29,01,373 Equity Shares at a price of INR 236/- per Equity Share aggregating to INR 2192,47,24,028/- (“Subscription Shares”) to BC Asia Investments XXV Limited securities, by way of a preferenal issue on a private placement basis for cash consideration on such terms and conditions as set out in the SSA and such other terms and conditions, as mutually agreed between the parties in the SSA, subject to applicable laws and regulations, and in accordance with Chapter V of the ICDR Regulations, (“Preferenal Issue”) (ii) 9,29,01,373 warrants, each carrying a right to subscribe to 1 (one) Equity Share, at a price of INR 236/- per warrant aggregating to INR 2192,47,24,028/- , which may be exercised and converted in one or more tranches during the period commencing from the expiry of 4 (four) months from the date of allotment of warrants till 18 (eighteen) months from the date of allotment of the warrants (“Subscripon Warrants”), to BC Asia Investments XIV LimitedMoreLess
1 for0 against
Mutual fund votes, meeting of 14 Aug 2024, 22 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
1 - To receive, consider and adopt the audited Standalone as well as Consolidated Financial Statements of the Company for the financial year ended March 31, 2024, together with Reports of the Board of Directors and Auditors thereon.MoreLess
21 for0 against- 2 - To appoint a director in place of Dr. Sumitha Nandan (DIN: 03625120), Executive Director of the Company who retires by rotation, and being eligible, offers herself for re-appointment.
Against Edelweiss Mutual Fund
- Edelweiss Mutual FundNo relevant experience
21 for1 against - 3 - Appointment of M/s. KKC & Associates LLP (ICAI Firm Registration No. 105146W/ W100621) as Joint Statutory Auditor of the Company and to fix their remuneration.22 for0 against
- 4 - Appointment of M/s. Chokshi & Chokshi LLP (ICAI Firm Registration No. 101872W/W100045) as Joint Statutory Auditor of the Company and to fix their remuneration22 for0 against
- 5 - Re-appointment of Mr. Abhijit Sen (DIN: 00002593) as Independent Director.
Against Groww Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual Fund
- Groww Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual FundNo concern on the merit of proposed appointee. Governance Concern: Proposed term may lead to Prolonged Association
19 for3 against - 6 - Revision in remuneration payable to Mr. V P Nandakumar (DIN: 00044512), Managing Director & Chief Executive Officer of the Company.
Against Aditya Birla Sun Life Mutual Fund, Axis Mutual Fund, Bandhan Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HSBC Mutual Fund, ICICI Prudential Mutual Fund, Invesco Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund, Sundaram Mutual Fund
- Aditya Birla Sun Life Mutual Fund, Axis Mutual Fund, DSP Mutual Fund, Sundaram Mutual FundHis proposed remuneration is estimated at Rs 257.7 mn, 50% being variable. His remuneration is also not commensurate with industry peers with commission being open ended at 1% of profits. The company must set a cap to commission so as to ensure remuneration is reasonable and in alignment with industry peers. We also note, the remuneration structure allows for reimbursement of expenses incurred by his spouse/one other person for travelling with him during business trips citing health/security reasons. We are of the opinion that attendant / family expenses as companion should be borne by the employee and not the company.
- Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual FundCompliant with law. Governance concern: No absolute cap on the Commission.
- Edelweiss Mutual FundRevision cannot be done on retrospecive basis.
- HSBC Mutual FundA vote AGAINST this resolution is warranted in view of the following concerns in the executive's remuneration: • The pay lacks an absolute cap on the commission element or on the overall remuneration. • The company has not disclosed the targets which would be used to determine the outcome under the commission element. • There are concerns on the historic alignment of pay with the performance of the company. • His estimated remuneration is aggressively positioned when compared to peers with similar size and scale of business operations.
- ICICI Prudential Mutual FundThere is no issue with the overall remuneration, but the remuneration structure allows for reimbursement of expenses incurred by his spouse/one other person for travelling with him during business trips citing health/security reasons. The AMS is of the opinion that attendant / family expenses as companion should be borne by the employee and not the company. Hence, the AMC has voted against the resolution.
- Invesco Mutual FundHis proposed remuneration is estimated at Rs. 257.7 mn, 50% being variable. His remuneration is also not commensurate with industry peers with commission being open ended at 1% of profits. The company must set a cap to commission so as to ensure remuneration is reasonable and in alignment with industry peers. We also note, the remuneration structure allows for reimbursement of expenses incurred by his spouse/one other person for travelling with him during business trips citing health/security reasons. We are of the opinion that attendant / family expenses as companion should be borne by the employee and not the company.
- Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
8 for14 against - 7 - Revision in remuneration payable to Dr. Sumitha Nandan (DIN: 03625120), Whole-time Director of the Company.
Against Aditya Birla Sun Life Mutual Fund, Axis Mutual Fund, Bandhan Mutual Fund, DSP Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, ICICI Prudential Mutual Fund, Invesco Mutual Fund, Mahindra Manulife Mutual Fund, Mirae Asset Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual Fund, Sundaram Mutual Fund
- Aditya Birla Sun Life Mutual Fund, Axis Mutual Fund, DSP Mutual Fund, Sundaram Mutual FundDr. Sumitha Nandan, 44, daughter of promoter and Managing Director, V.P. Nandakumar was appointed on 1 January 2023. For FY24, her remuneration was Rs. 15.5 mn. Her remuneration post revision is estimated at Rs 22.7 which is high in comparison to remuneration paid to Senior Management Personnel in the company with more relevant experience. Her remuneration structure has a minimum annual increase of 10% in fixed pay: the company just disclose if such minimum increases in fixed pay are committed to all other employees as well. Dr. Sumitha Nandan is entitled to commission, which is open ended at 1% of profits which could result in a remuneration higher that estimated. The company must cap the overall commission/variable pay and disclose the performance parameters considered to determine the variable pay.
- Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, PGIM India Mutual FundCompliant with law. Governance concern: No absolute cap on the Commission.
- Edelweiss Mutual FundRevision cannot be done on retrospecive basis.She has no relevant experience too
- ICICI Prudential Mutual FundDr. Sumitha Nandan’s (daughter of promoter and Managing Director, V.P. Nandakumar) remuneration is high in comparison to remuneration paid to Senior Management Personnel in the company with more relevant experience. Hence, the AMC has voted against the resolution.
- Invesco Mutual FundDr. Sumitha Nandan, 44, daughter of promoter and Managing Director, V.P. Nandakumar was appointed on 1 January 2023. For FY24, her remuneration was Rs. 15.5 mn. Her remuneration post revision is estimated at Rs. 22.7 which is high in comparison to remuneration paid to Senior Management Personnel in the company with more relevant experience. Her remuneration structure has a minimum annual increase of 10% in fixed pay: the company just disclose if such minimum increases in fixed pay are committed to all other employees as well. Dr. Sumitha Nandan is entitled to commission, which is open ended at 1% of profits which could result in a remuneration higher that estimated. The company must cap the overall commission/variable pay and disclose the performance parameters considered to determine the variable pay.
- Mahindra Manulife Mutual FundDr. Sumitha Nandan, 44, daughter of promoter and Managing Director, V.P. Nandakumar was appointed on 1 January 2023. For FY24, her remuneration was Rs. 15.5 mn. Her remuneration post revision is estimated at Rs 22.7 which is high in comparison to remuneration paid to Senior Management Personnel in the company with more relevant experience. Her remuneration structure has a minimum annual increase of 10% in fixed pay: the company just disclose if such minimum increases in fixed pay are committed to all other employees as well. Dr. Sumitha Nandan is entitled to commission, which is open ended at 1% of profits which could result in a remuneration higher that estimated. We do not support the resolution.
- Mirae Asset Mutual FundAs per advisory recommendation (Passive holding)
8 for14 against
1 proposal not matched to one resolution
- Accept Financial Statements and Statutory Reports1 for0 against
Mutual fund votes, meeting of 11 May 2024, 22 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
- Approval to borrow in excess of the aggregate of paid-up share capital and free reserves and securities premium of the Company under Section 180(1)(c) of the Companies Act, 2013.17 for0 against
- Approval to create charge/ mortgage over the properties of the Company for the purpose of borrowing in terms of Section 180(1)(a) of the Companies Act, 2013.21 for0 against
4 proposals not matched to one resolution
- 1) To approve increase in borrowing limits from Rs. 300.0 bn to Rs. 400.0 bn.1 for0 against
- Approve Borrowing Powers1 for0 against
- Approve Pledging of Assets for Debt1 for0 against
- To approve increase in borrowing limits from Rs. 300.0 bn to Rs. 400.0 bn3 for0 against
Mutual fund votes, meeting of 3 Apr 2024, 20 fund houses
- Appointment of Mr. Edodiyil Kunhiraman Bharat Bhushan (DIN: 01124966) as Non-Executive Independent Director of the Compan20 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Fines, tax disputes and stakes in unlisted companies
Reported in the filing for the quarter to Jun 2026.
- Unlisted stake boughtAsirvad Micro Finance LimitedSince 10 Apr 2026
0.41% bought in the quarter; holding 98.97%, from 98.56%
- Unlisted stake heldManappuram Home Finance LimitedSince 10 Apr 2026
0.00% bought in the quarter; holding 100.00%, from 100.00%
- Fine or penaltySEBISince 28 Apr 2026
Penalty of Rs. 1Lakh imposed on Asirvad Micro Finance Limited, a Subsidiary Company w.r.t down selling of NCDs issued under ISIN INE516Q08281 by Karvy Capital Limited
W.r.t Asirvad Micro Finance Limited, a subsidiary Company, in reference to the Show Cause Notice No. SEBI/EAD/BM/GN/28176/1/2024 dated September 03, 2024 (“SCN”), issued under Rule 4(1) of the SEBI (Procedure for Holding Inquiry and Imposing Penalties) Rules, 1995, alleging violations of certain provisions of the Companies Act, 2013, Companies (Share Capital and Debenture) Rules, 2014; and Securities and Exchange Board of India (Issue and Listing of Debt Securities) Regulations, 2008 on issuance of NCDs to Karvy Capital Limited (“KCL”) which were subsequently down-sold to multiple investors prior to listing, resulting in 739 holders.MoreLess
- Tax disputeACIT, Central Circle, ThrissurSince 25 Apr 2026
Income Tax related: AY 2020-21: Order giving effect (based on Order u/s 250 dated 30-05-2025) received dated 10-04-2026 with a demand of Rs.8.87Cr. We had filed a rectification request dated 28-04-2026 against the Order as the Computation Sheet did not considered Regular Assessment Tax paid Rs.5.94Cr(refund adjusted from AY 2021-22) along with some other mistakes apparent on record.MoreLess
At the filing before: Order received on this quarter (10-04-2026) - Tax disputeDeputy Commissioner (ST), Coimbatore, Tamil NaduSince 29 May 2026
GST (Tamil Nadu state) related to FY 2021-22 : Refund application related appeal (Rs. 2.76 lakhs) rejected by the first appeallate authority on 29.05.2026. Company to file second level appeal with GSTAT/ROM application in this regard. The due date for filing appeal/ROM is 28.08.2026MoreLess
At the filing before: Order received on this quarter (29-05-2026) - Tax disputeDeputy Commissioner (ST), Coimbatore, Tamil NaduSince 27 Jun 2026
GST (Tamil Nadu state) related to FY 2020-21: First level appellate authority had issued order during March 2026 uphelding the underlying jurisdictional officers demand of Rs. 4.66 Crores. The Company has filed an appeal with GSTAT against the same on 27.06.2026. Hearing awaitedMoreLess
At the filing before: First level appellate authority had issued order during March 2026 uphelding the underlying jurisdictional officers demand of Rs. 4.66 Crores.
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- Yes
- The filing has a part on fines and penalties
- Yes
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Jun 2026. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere |
|---|---|---|---|---|---|
| Preferential IssuesMar 2026, checked by Crisil Ratings Limited | 2,740.59 | – | – | No |